The Ministry of Health and Family Welfare, through the Indian Pharmacopoeia Commission, has launched the 6th National Pharmacovigilance Week. The week-long observance will run from 17 to 23 September 2026 across the country. It aims to educate healthcare workers, researchers and the general public about reporting adverse drug reactions and the importance of monitoring medicine safety.
What the week covers
The theme for this year’s campaign is “Promoting Rational Use of Medicines through Pharmacovigilance – A Step Towards Safer Healthcare”. The Indian Pharmacopoeia Commission acts as the National Coordination Centre for the Pharmacovigilance Programme of India.
During the week, officials plan to raise awareness about adverse drug reaction reporting among healthcare professionals and the public. The commission aims to encourage people to actively participate in reporting any harmful effects linked to medicines.
A key goal outlined at the inaugural event is to expand the monitoring network to grassroots level. The vision includes establishing at least one Adverse Drug Reaction Monitoring Centre and one Medical Device Monitoring Centre in every Aspirational District. Officials also plan to use the safety data collected through pharmacovigilance to support better, more rational use of medicines and explore opportunities for drug repurposing.
The inauguration ceremony saw the release of Volume 16, Issue 2 (2026) of the Pharmacovigilance Programme of India Newsletter, which documents the programme’s work in strengthening medicine safety awareness.
What this means for you
If you are a patient experiencing unexpected side effects from any medicine, you now have a formal system to report it during this week and beyond. Healthcare workers are being encouraged to document and report such cases, which helps authorities identify unsafe medicines or dosages. For doctors and nurses, the week emphasises using pharmacovigilance data to make better treatment decisions and choose medicines more carefully. The focus on rational medicine use means future prescriptions should aim to give you the right drug at the right dose, reducing harm while improving treatment outcomes.